Insulin restores l-arginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia

Placenta

Volumn 36, Issue 3, 2015, Pages 287-296

  Salsoso, R ^a   Guzman Gutierrez E ^a,e   Saez T ^a   Bugueno K ^a,b   Ramirez M A ^b   Farias M ^a   Pardo, F ^a   Leiva, A ^a   Sanhueza, C ^a   Mate, A ^c   Vazquez C ^c   Sobrevia, L ^a,c,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE ANTOFAGASTA   (Chile)

^c UNIVERSITY OF SEVILLE   (Spain)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Adenosine receptor; Arginine; Foetal endothelium; Insulin; Preeclampsia

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; AMINO ACID TRANSPORTER; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; N(G),N(G) DIMETHYLARGININE; ADENOSINE A2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT;

ADULT; AMINO ACID TRANSPORT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPORT KINETICS; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL; VEIN DILATATION; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; IN VITRO STUDY; INSULIN RESISTANCE; METABOLISM; PATHOLOGY; PRE-ECLAMPSIA; SIGNAL TRANSDUCTION; THIRD TRIMESTER PREGNANCY; TRANSPORT AT THE CELLULAR LEVEL; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ADULT; ARGININE; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOGLYCEMIC AGENTS; IN VITRO TECHNIQUES; INSULIN; INSULIN RESISTANCE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; UMBILICAL VEINS; YOUNG ADULT;

EID: 84922935833     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.12.007     Document Type: Article

References (31)

1. A. Mate, C.M. Vázquez, A. Leiva, and L. Sobrevia New therapeutic approaches to treating hypertension in pregnancy Drug Discov Today 17 2012 1307 1315
2. American College of Obstetricians and Gynecologists, and Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and gynecologists' task force on hypertension in pregnancy Obstet Gynecol 122 2013 1122 1131
3. T. Dorniak-Wall, R.M. Grivell, G.A. Dekker, W. Hague, and J.M. Dodd The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials J Hum Hypertens 28 2014 230 235
4. G. Benedetti, K.L. Morais, J.R. Guerreiro, E.F. de Oliveira, M.S. Hoshida, and L. Oliveira Bothrops jararaca peptide with anti-hypertensive action normalizes endothelium dysfunction involved in physiopathology of preeclampsia PLoS One 6 2011 e23680
5. J.A. González-Garrido Chem, I.M. Olivares-Corichi, J.M. Tovar-Rodriguez, N.A. Hernández-Santana, E. Méndez-Bolaina, and G.M. Ceballos-Reyes Influence of the AT2 receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia J Hum Hypertens 27 2013 355 361
6. M.L. Miranda Guisado, A.J. Vallejo-Vaz, P.S. García Junco, L. Jiménez Jiménez, S. García Morillo, and O. Muñiz Grijalvo Abnormal levels of antioxidant defenses in a large sample of patients with hypertensive disorders of pregnancy Hypertens Res 35 2012 274 278
7. Y.J. Kim, H.S. Park, H.Y. Lee, E.H. Ha, S.H. Suh, and S.K. Oh Reduced L-arginine level and decreased placental eNOS activity in preeclampsia Placenta 27 2006 438 444
8. P. Tamás, J. Bódis, E. Sulyok, G.L. Kovács, E. Hantosi, and G. Molnár L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies Scand J Clin Lab Invest 73 2013 436 443
9. T.A. Hardy, and J.M. May Coordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cells Free Radic Biol Med 32 2002 122 131
10. P.F. Speake, J.D. Glazier, P.T. Ayuk, M. Reade, C.P. Sibley, and S.W. D'Souza L-Arginine transport across the basal plasma membrane of the syncytiotrophoblast of the human placenta from normal and preeclamptic pregnancies J Clin Endocrinol Metab 88 2003 4287 4292
11. E. Guzmán-Gutiérrez, F. Westermeier, C. Salomón, M. González, F. Pardo, and A. Leiva Insulin-increased L-arginine transport requires A2A adenosine receptors activation in human umbilical vein endothelium PLoS One 7 2012 e41705
12. F. Westermeier, C. Salomón, M. González, C. Puebla, E. Guzmán-Gutiérrez, and F. Cifuentes Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium Diabetes 60 2011 1677 1687
13. E. Guzmán-Gutiérrez, P. Arroyo, R. Salsoso, B. Fuenzalida, T. Sáez, and A. Leiva Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in gestational diabetes mellitus Microcirculation 21 2014 26 37
14. J. Espinoza, A.F. Espinoza, and G.G. Power High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol 205 2011 e24 e27
15. Y. Yoneyama, R. Sawa, S. Suzuki, S. Shin, G.G. Power, and T. Araki The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia Am J Obstet Gynecol 174 1996 267 271
16. C. Escudero, and L. Sobrevia A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium Placenta 29 2008 469 483
17. C. Escudero, P. Bertoglia, M. Hernandez, C. Celis, M. Gonzalez, and C. Aguayo Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia Purinergic Signal 9 2013 215 226
18. B.B. Fredholm, A.P. Ijzerman, K.A. Jacobson, J. Linden, and C.E. Müller International Union of Basic and Clinical Pharmacology. Nomenclature and classification of adenosine receptors - an update Pharmacol Rev 63 2011 1 34
19. R. Salsoso, E. Guzmán-Gutiérrez, P. Arroyo, C. Salomón, S. Zambrano, and M.V. Ruiz-Armenta Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats PLoS One 9 2014 e90339
20. R. D'Anna, G. Baviera, F. Corrado, D. Giordano, A. De Vivo, and G. Nicocia Adiponectin and insulin resistance in early- and late-onset pre-eclampsia Br J Obstet Gynecol 113 2006 1264 1269
21. T. Firoz, L. Magee, K. MacDonell, B. Payne, R. Gordon, M. Vidler the Community Level Interventions for Pre-eclampsia (CLIP) Working Group Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review Br J Obstet Gynecol 2014 10.1111/1471-0528.12737
22. C. Escudero, P. Casanello, and L. Sobrevia Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia Placenta 29 2008 816 825
23. I. Fleming Molecular mechanisms underlying the activation of eNOS Pflugers Arch 459 2010 793 806
24. I. Fleming, and R. Busse Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase Am J Physiol 284 2003 R1 R12
25. P.N. Alpoim, L.C. Godoi, L.G. Freitas, K.B. Gomes, and L.M. Dusse Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia Nitric Oxide 33 2013 81 82
26. R. San Martín, and L. Sobrevia Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium Placenta 27 2006 1 10
27. M.J. Nel, A.J. Woodiwiss, and G.P. Candy Modeling of cellular arginine uptake by more than one transporter J Membr Biol 245 2012 1 13
28. G.J. Burton, M. Scioscia, and T.W. Rademacher Endometrial secretions: creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia J Reprod Immunol 89 2011 118 125
29. L.V. Ravichandran, R.A. Johns, and A. Rengasamy Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide Am J Physiol 268 1995 H2216 H2223
30. Y.-H. Weng, Ch.-Y. Kuo, Y.-W. Chiu, M.-L. Kuo, and S.-L. Liao Alteration of nitric oxide gas on gene expression of endothelin-1 and endothelial nitric oxide synthase by a time- and dose-dependent manner in human endothelial cells Chin J Physiol 52 2009 59 64
31. F. Westermeier, C. Salomón, M. Farías, P. Arroyo, B. Fuenzalida, and T. Sáez Insulin requires normal expression and signalling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium FASEB J 29 2015 10.1096/fj.14-254219